Signaling Pathway
Important Notice: For research use only. We do not sell to patients.
Not your Region? View all Distributors
| Discription | L-779450 is a raf kinase inhibitor, a potential treatment for neurotraumatic diseases. | ||
|---|---|---|---|
| Targets |
|
| Catalog Num | A13525 |
|---|---|
| Formula | C20H14ClN3O |
| Molecular Weight | 347.8 |
| CAS Number | 303727-31-3 |
| SMILES | C1=CC=C(C=C1)C2=NC(=C(N2)C3=CC=NC=C3)C4=CC(=C(C=C4)Cl)O |
| Synonyms | L-779,450 |
| Storage | Store lyophilized at -20ºC, keep desiccated. |
| In vitro | DMSO | 62 mg/mL (178.26 mM) | |
| Water | Insoluble | ||
| Ethanol | Insoluble | ||
|
* <1 mg/ml means slightly soluble or insoluble. * Please note that Adooq tests the solubility of all compounds in-house, and the actual solubility may differ slightly from published values. This is normal and is due to slight batch-to-batch variations. |
|||
| Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
|---|---|---|---|
| 0.1 mM | 28.75 mL | 143.76 mL | 287.52 mL |
| 0.5 mM | 5.75 mL | 28.75 mL | 57.5 mL |
| 1 mM | 2.88 mL | 14.38 mL | 28.75 mL |
| 5 mM | 0.58 mL | 2.88 mL | 5.75 mL |
Calculate the dilution required to prepare a stock solution. This equation is commonly abbreviated as: C1V1 = C2V2
